Cardiovascular Risk Stratification in Patients With Obstructive Sleep Apnea

Status

UNKNOWN

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00768625

Acronym

ERA

Enrollment

2000

Registered

2008-10-08

Start date

2005-04-30

Completion date

2012-12-31

Last updated

2008-10-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Obesity, Obstructive Sleep Apnea

Brief summary

The purpose of this study is: 1. To determine the frequency of cardiovascular diseases in patients with OSA, obese, overweight, and lean (BMI\<25) 2. To analyze the CPAP treatment over the clinical evolution of OSA patients 3. To determine if OSA is a independent predictor of cardiovascular risk

Detailed description

Obstructive Sleep Apnea (OSA) is a condition with important cardiovascular repercussions. However, the association between OSA, cardiovascular diseases, and obesity has not been totally clarified. We hypothesized that the cardiovascular consequences of OSA are due to obesity.

Interventions

None listed

Study design

Observational model

COHORT

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

30 Years to 65 Years

Healthy volunteers

Yes

Inclusion criteria

* Men and women with OSA (apnea-hypopnea index higher than 5 events/hour)

Exclusion criteria

* Body mass index higher than 40

Design outcomes

Primary

Measure	Time frame
Cardiovascular events	five years

Countries

Brazil

Contacts

Primary ContactFatima D Cintra, MD, PhD

fatimacintra@interair.com.br55 11 99698555

Outcome results